- New Legislation Will Help Schools Handle Heart Emergencies
- Money, Gun Violence, Hate Crimes: Poll Reveals Top Worries at the End of 2024
- Bird Flu Kills 20 Big Cats at Washington Sanctuary, Causing Quarantine
- Proposed FDA Rule Targets Asbestos in Talc Cosmetic Products
- In Kids with Crohn’s Disease, TNF Inhibitors Help Prevent Serious Complications, Data Suggests
- Has RSV Vaccine Hesitancy Subsided?
- Study: Blood Transfusion Post-Heart Attack May Be Critical for Those with Anemia
- FDA Approves Generic GLP-1 Medicine For Diabetes Treatment
- Quick Fix? New Migraine Medicine May Start Working Right Away
- Food Recall Update: Class 1 Alert Issued for Costco Eggs Linked to Salmonella
Health Highlights: July 23, 2021
Here’s some of HealthDay’s top stories for Friday, July 23:
Arguing for & against approval of controversial Alzheimer’s drug. The FDA earlier this month gave its OK to the first new Alzheimer’s drug in years — despite its own panel voting 10-1 against approval. Now, some doctors and hospitals are refusing to use the expensive drug, called Aduhelm. Who’s right? Read more
Are antibiotics the only answer for UTIs? Millions of women are stricken with a urinary tract infection each year, and the typical response from their doctors is a prescription for antibiotics. But is that really solving the problem?Read more
A new drug offers hope against psychosis. Hallucinations, delusions, agitation: Hallmarks of psychotic episodes, which can incapacitate the frail or ill and create a huge burden for caregivers. Now, research suggests that a drug that’s been effective against Parkinson’s psychosis may work for other forms of the condition. Read more
Copyright © 2024 HealthDay. All rights reserved.